Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sch 14714
1. 38677-85-9
2. Flunixine
3. Sch 14714
4. Flunixino
5. Flunixinum
6. Sch-14714
7. 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)nicotinic Acid
8. Chebi:76138
9. 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinic Acid
10. 2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic Acid
11. 356ib1o400
12. 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic Acid
13. 3-pyridinecarboxylic Acid, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-
14. Flunixin [usan]
15. Flunixine [inn-french]
16. Flunixinum [inn-latin]
17. Flunixino [inn-spanish]
18. 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxylic Acid
19. 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid
20. 3-pyridinecarboxylic Acid, 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]-
21. Flunixin [usan:inn:ban]
22. Flunixin-meglumin
23. Unii-356ib1o400
24. 2(2'-methyl-3'-trifluoromethylanilino)nicotinic Acid
25. Flunixin (usan/inn)
26. Flunixin [inn]
27. Flunixin [mi]
28. 2-(alpha(sup 3),alpha(sup 3),alpha(sup 3)-trifluoro-2,3-xylidino)nicotinic Acid
29. Schembl42911
30. Mls004712071
31. Flunixin [green Book]
32. Sch14714
33. Zinc1467
34. Chembl1617398
35. Dtxsid4048565
36. 2-[2-methyl-3-(trifluoromethyl)phenylamino]nicotinic Acid
37. Bcp12991
38. Bdbm50201618
39. Mfcd00072033
40. Akos015963218
41. Ac-1265
42. Db11518
43. Flunixin 100 Microg/ml In Acetonitrile
44. Smr000857255
45. Ft-0626444
46. Flunixin, Vetranal(tm), Analytical Standard
47. Vu0244596-2
48. D04215
49. 677f859
50. Q906934
51. Sr-01000883753
52. Sr-01000883753-1
53. 2-(2-methyl-3-trifluoromethylanilino) Nicotinic Acid
54. Brd-k99984802-098-03-2
55. Brd-k99984802-100-01-0
56. Brd-k99984802-100-06-9
57. 2-(alpha(3),alpha(3),alpha(3)-trifluoro-2,3-xylidino)nicotinic Acid
58. 2-(.alpha.(sup 3),.alpha.(sup 3),.alpha.(sup 3)-trifluoro-2,3-xylidino)nicotinic Acid.
59. Jbo
| Molecular Weight | 296.24 g/mol |
|---|---|
| Molecular Formula | C14H11F3N2O2 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 296.07726208 g/mol |
| Monoisotopic Mass | 296.07726208 g/mol |
| Topological Polar Surface Area | 62.2 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 376 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Antipyretics
Drugs that are used to reduce body temperature in fever. (See all compounds classified as Antipyretics.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
35
PharmaCompass offers a list of Flunixin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Flunixin manufacturer or Flunixin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Flunixin manufacturer or Flunixin supplier.
PharmaCompass also assists you with knowing the Flunixin API Price utilized in the formulation of products. Flunixin API Price is not always fixed or binding as the Flunixin Price is obtained through a variety of data sources. The Flunixin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Flunixin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flunixin, including repackagers and relabelers. The FDA regulates Flunixin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flunixin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flunixin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flunixin supplier is an individual or a company that provides Flunixin active pharmaceutical ingredient (API) or Flunixin finished formulations upon request. The Flunixin suppliers may include Flunixin API manufacturers, exporters, distributors and traders.
click here to find a list of Flunixin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Flunixin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flunixin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flunixin GMP manufacturer or Flunixin GMP API supplier for your needs.
A Flunixin CoA (Certificate of Analysis) is a formal document that attests to Flunixin's compliance with Flunixin specifications and serves as a tool for batch-level quality control.
Flunixin CoA mostly includes findings from lab analyses of a specific batch. For each Flunixin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flunixin may be tested according to a variety of international standards, such as European Pharmacopoeia (Flunixin EP), Flunixin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flunixin USP).
